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Abstract
Background: Abnormal serum sodium concentrations are common in patients presenting for surgery. It remains unclear
whether these abnormalities are independent risk factors for postoperative mortality.
Methods: This is a secondary analysis of the European Surgical Outcome Study (EuSOS) that provided data describing 46 539
patients undergoing inpatient non-cardiac surgery. Patients were included in this study if they had a recorded value of
preoperative serum sodiumwithin the 28 days immediately before surgery. Data describing preoperative risk factors and serum
sodium concentrations were analysed to investigate the relationship with in-hospital mortality using univariate and
multivariate logistic regression techniques.
Results: Of 35 816 (77.0%) patients from the EuSOS database, 21 943 (61.3%) had normal values of serum sodium (138–142mmol
litre−1) before surgery, 8538 (23.8%) had hyponatraemia (serumsodium≤137mmol litre−1) and 5335 (14.9%) had hypernatraemia
(serum sodium ≥143 mmol litre−1). After adjustment for potential confounding factors, moderate to severe hypernatraemia
(serum sodium concentration ≥150 mmol litre−1) was independently associated with mortality [odds ratio 3.4 (95% confidence
interval 2.0–6.0), P<0.0001]. Hyponatraemia was not associated with mortality.
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Conclusions: Preoperative abnormalities in serumsodiumconcentrations are common, andhypernatraemia is associatedwith
increased mortality after surgery. Abnormalities of serum sodium concentration may be an important biomarker of
perioperative risk resulting from co-morbid disease.
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Editor’s key points
• Abnormalities of serum sodium (dysnatraemia) are likely to
be associated with increased perioperative risk.
• Dysnatraemias aremore common in thosewith co-morbid-
ity or undergoing emergency surgery.
• Dysnatraemia could be a useful biomarker of perioperative
risk and warrant further investigation before surgery.
Postoperative mortality and morbidity are significant problems
for health-care systems.1–3 A better understanding of the pre-
operative factors associated with postoperative complications
could lead to improved methods of risk stratification. This
could allow more effective allocation of perioperative care re-
sources in order to maximize the benefit to the greatest number
of patients.4–6 A number of tests are routinely performed before
surgery, but the predictive utility of most investigations is un-
clear.7 8 The UK National Institute for Health and Care Excellence
(NICE) has confirmed the paucity of information regarding the
clinical value of preoperative electrolyte testing.
Serum sodium concentrations are commonlymeasured before
major surgery. Sodium, chloride, and bicarbonate ions contribute
∼90% of the extracellular osmolality. In normal homeostatic con-
ditions, serum sodium concentrations are maintained within a
very tight range (138–142 mmol litre−1), although values slightly
outside this range are often considered normal. Previous studies
suggest that dysnatraemia, defined as either hyponatraemia or
hypernatraemia, is associated with worse outcomes in medical
and surgical patients in both hospital wards and intensive care
units (ICUs)9–14 and is associated with increased health-care
costs.15 However, there are few published data exploring the asso-
ciation between preoperative dysnatraemia and postoperative
adverse outcomes. Recently, Leung and colleagues16 17 reported
that both preoperative hypo- and hypernatraemia are independ-
ently associated with increased hospital mortality, length of hos-
pital stay, and complications in surgical patients. Similar
associations have been found in postsurgical ICUs.18 Given that
derangements of serum sodium are detected using routine pre-
operative blood tests and are potentially treatable, understanding
the implications of dysnatraemia for perioperative outcomes is of
great importance.
We therefore performed a secondary analysis of data col-
lected during the European Surgical Outcomes Study (EuSOS)19
to describe the relationship between preoperative serum sodium
concentration and postoperative mortality, in order to evaluate
whether dysnatraemia is independently associated with death
after surgery.
Methods
This study is a secondary analysis of data collected during amajor
prospective observational study of non-cardiac surgery (EuSOS).
The investigators collecteddataonall patientsundergoing surgery
in participating hospitals within a 1week period in April 2011. Full
methodological details can be found in the original publication.19
All surgical patients were enrolled unless they were <16 yr of age
or were having outpatient, obstetric, cardiac, or neurosurgical
procedures.
Cohort description
Patients were included in this analysis if there were complete
data describing preoperative serum sodium measurements and
postoperative hospital mortality in the database. For the pur-
poses of the present study, a preoperative serum sodium meas-
urement was the most recent measurement performed within
the 28 days before surgery. Patientswere excluded if theywere re-
cruited in a hospital that provided data describing 10 patients or
fewer in the study week, or in hospitals above the 95th centile for
mortality.
Definitions
For the analyses, seven intervals were defined from severe hypo-
natraemia to severe hypernatraemia,with the reference serumso-
dium interval defined as being between 138 and 142 mmol litre−1.
Statistical analysis
The primary outcome measure was in-hospital mortality, cen-
sored at 30 days. Statistical analyses were performed with SAS
(version 9.2, produced by Statistical Analytical Software, North
Carolina State Universtity, USA) and R (version 2.13.0 produced
by R Development Core Team). Categorical variables are pre-
sented as n (%) and continuous variables as mean (). Results
of statistical models are reported as adjusted odds ratios (ORs)
with 95% confidence intervals (CIs).
General estimating equations were used to assess the associ-
ation between preoperative serum concentration and subse-
quent postoperative in-hospital mortality. First, the association
between the risk factors and in-hospital mortality was explored
using logistic regression analysis, including the dysnatraemia
groups as fixed factors only. All factors significantly associated
with mortality (P<0.05) were then entered as covariables into a
general estimating equation regression model, accounting for
clustering of patients within sites. Patients were excluded if
their data were missing values for any of the covariates. Patients
with serum sodium concentrations within the normal range
(138–142 mmol litre−1) were used as the reference group. To
account for multiple comparisons, an adjusted two-sided signifi-
cance level of P<0.008 (0.05/6) was applied.
In order to illustrate graphically the association between pre-
operative serum sodiumconcentration andmortality, a logistic re-
gression function was estimated using splines. We expected the
association between mortality and extreme values for serum so-
dium concentrations to be unreliable because of low patient num-
bers. Patients with serum sodium values from the lowest and
highest 0.25% of valueswere therefore excluded from the analysis.
In a secondary analysis, resource utilization variables were com-
pared across the sodium categories in univariate analysis using
the analysis of variance () and χ2 tests.
Three sensitivity analyses were performed to assess the ro-
bustness of the results. Two multivariate generalized estimating












equation regression models were developed using the categories
of hyponatraemia, normal serum sodium, and hypernatraemia,
where borderline dysnatraemiawas included in either the normal
or dysnatraemia groups. To adjust for multiple testing (compari-
son of the two dysnatraemia groups with reference) an adjusted
two-sided significance level of P<0.025 (0.05/2) was applied. A
number of sensitivity analyses were performed. These included
the following: (i) amultiple imputationmethodology thatwas per-
formed to account for the influence of selection bias through pre-
operative sodium measurements; and (ii) a propensity score
analysis that was performed to account further for this factor.
The propensity score-matched analysis was performed for the
multivariate model for hospital mortality, adjusting it based on
the propensity score for serum sodium measurement. The pro-
pensity score was calculated using logistic regression on the full
data set, including patients with no available data describing
serum sodium, and then introduced into the multivariate model.
Results
Cohort description and prevalence of dysnatraemias
From the full EuSOS cohort of 46 539 patients, a total of 35 816
patients were included in this analysis (Table 1 and Supplemen-
tary data Table S1). The mean () age was 59 (18) yr, and 17 683
patients (49%) were male. Of the total number of patients,
26 282 (73%) were presenting for elective surgery. For 21 943
(61.3%) patients, the serum sodium measurement was within
the 138–142 mmol litre−1 interval, whereas 8538 (23.8%) patients
were hyponatraemic (serum sodium ≤137 mmol litre−1) and 5335
(14.9%) were hypernatraemic (serum sodium concentrations
≥143 mmol litre−1). Patients presenting with dysnatraemia were
more likely to undergo emergency surgery (Table 1) and to pre-
sent with co-morbid disease (Table 2). Hyponatraemia and hy-
pernatraemia were twice as frequent in patients with cirrhosis,
congestive heart failure, or coronary artery disease as in those
who did not have these diseases. Hyponatraemia was also
more prevalent in patients with chronic obstructive pulmonary
disease (Table 2).
Association of dysnatraemias with mortality
In the univariate analysis, both hyponatraemia and moderate to
severe hypernatraemiawere associated with increasedmortality
(Table 3). In the logistic regressionmodel, after correcting for age,
gender, ASA score, co-morbid disease, surgical procedure cat-
egory, severity, grade, and urgency of surgery, only moderate
and severe hypernatraemiawere significantly associatedwith in-
creased mortality [OR 3.4 (95% CI 2.0–6.0), P<0.001]. The associ-
ation between mortality and serum sodium concentration is
Table 1 Basic patient characteristics of cohort split by preoperative serum sodium measurement. COPD, chronic obstructive pulmonary
disease






















Number of patients [n (%)] 35 816 (100) 602 (1.7) 3338 (9.3) 4598 (12.8) 21 943 (61.3) 3805 (10.6) 1422 (4.0) 108 (0.3)
Age (yr) 58.5 (18.2) 67.2 (16.2) 63.0 (17.9) 58.5 (18.9) 57.3 (18.1) 59.2 (17.1) 60.4 (17.5) 62.8 (18.9) <0.0001
Male sex [n (%)] 17 683 (49) 303 (50.3) 1686 (50.5) 2322 (50.5) 10 740 (49.0) 1861 (48.9) 712 (50.1) 59 (54.6) 0.26
Urgency of surgery [n (%)]
Elective 26 282 (73.4) 252 (41.9) 1732 (51.9) 2998 (65.2) 16 988 (77.4) 3129 (82.2) 1130 (79.5) 53 (49.1) <0.0001
Urgent 7394 (20.6) 257 (42.7) 1189 (35.6) 1228 (26.7) 3932 (17.9) 532 (14) 223 (15.7) 33 (30.6) <0.0001
Emergency 2140 (6) 93 (15.5) 417 (12.5) 372 (8.1) 1023 (4.7) 144 (3.8) 69 (4.9) 22 (20.4) <0.0001
General anaesthesia 27 804 (77.6) 463 (76.9) 2557 (76.6) 3605 (78.4) 17 111 (78.0) 2908 (76.4) 1073 (75.5) 87 (80.6) 0.05
ASA score [n (%)]
I 7732 (21.6) 40 (6.7) 389 (11.7) 943 (20.6) 5246 (24.0) 823 (21.7) 277 (19.6) 14 (13.0) <0.0001
II 16 619 (46.5) 178 (29.8) 1263 (37.9) 1956 (42.6) 10 625 (48.5) 1901 (50) 666 (47) 30 (27.8) <0.0001
III 9929 (27.8) 297 (49.7) 1368 (41.0) 1423 (31.0) 5426 (24.8) 978 (25.7) 402 (28.4) 35 (32.4) <0.0001
IV 1389 (3.9) 77 (12.9) 299 (9.0) 248 (5.4) 570 (2.6) 100 (2.6) 69 (4.9) 26 (24.1) <0.0001
V 78 (0.2) 6 (1) 14 (0.4) 19 (0.4) 33 (0.2) 0 (0) 3 (0.2) 3 (2.8) <0.0001























Cirrhosis 427 (1.2%) 26 (4.3%) 81 (2.4%) 61 (1.3%) 194 (0.9%) 38 (1%) 22 (1.6%) 5 (4.6%) <0.0001
Congestive heart failure 1830 (5.1%) 72 (11.9%) 271 (8.1%) 275 (6.0%) 939 (4.3%) 174 (4.6%) 86 (6.1%) 13 (12.0%) <0.0001
COPD 4220 (12.0%) 104 (17.2%) 515 (15.5%) 569 (12.4%) 2423 (11.1%) 412 (10.8%) 186 (13.1%) 11 (10.2%) <0.0001
Coronary artery disease 5289 (15%) 147 (24.4%) 709 (21.3%) 754 (16.4%) 2900 (13.2%) 532 (14%) 225 (15.8%) 22 (20.4%) <0.0001
Diabetes mellitus ID 1786 (5%) 70 (11.6%) 326 (9.8%) 304 (6.6%) 884 (4.0%) 136 (3.6%) 59 (4.2%) 7 (6.5%) <0.0001
Diabetes mellitus NID 2919 (8.2%) 71 (11.8%) 373 (11.2%) 428 (9.3%) 1637 (7.5%) 283 (7.4%) 116 (8.2%) 11 (10.2%) <0.0001
Metastatic cancer 1898 (5.3) 61 (10.1%) 265 (8.0%) 272 (5.9%) 1026 (4.7%) 196 (5.2%) 66 (4.7%) 12 (11.1%) <0.0001
Stroke 1748 (4.9%) 53 (8.8%) 236 (7.1%) 260 (5.7%) 953 (4.4%) 163 (4.3%) 74 (5.2%) 9 (8.3%) <0.0001












shown in Figure 1. Overall, patients with serum sodium concen-
trations <136mmol litre−1 represented 11% of the overall popula-
tion and accounted for 243 deaths (6.2% mortality in this
category), which represented 20.1% of all deaths. Patients with
a serum sodium>144mmol litre−1 represented 4.3% of the overall
population. They accounted for 87 deaths (5.7% mortality in this
category) and 7.4% of all deaths. Both hypo- and hypernatraemia
were associated with a three-fold greater use of central venous
catheters during surgery. Patients with serum sodium <130 or
>150 mmol litre−1 were, respectively, three and five times more
likely to be admitted to critical care after surgery. The use of
both mechanical ventilation and inotropic support in the imme-
diate postoperative period was also greater for patients with dys-
natraemia (Table 4). Graphical representation of mortality in the
overall, the elective, and the non-elective population is present in
Figure 2.
Sensitivity analyses
Owing to the proportion of patients with missing serum sodium
values in the initial cohort (21%), a multiple imputation analysis
was performed, which confirmed the original multivariate ana-
lysis. A propensity analysis with probability of having serum so-
diummeasured being the outcomewas conducted to validate the
association between preoperative serum sodium and mortality.
The effect of serum sodium on mortality was significant even
after this adjustment, meaning that the association between
serum sodium andmortality weremaintained even after correct-
ing for this factor (see Supplementary data Table S4).
Discussion
The principal findings of this study were that dysnatraemia was
common in patients presenting for non-cardiac surgery, andwas
significantly associated withmortality. However, after correction
for confounding factors, only severe hypernatraemia was inde-
pendently associated with mortality. Our results suggest that
although abnormal serum sodium concentrations may be asso-
ciated with adverse postoperative outcomes, it is likely that the
underlying cause of the abnormality has much greater prognos-
tic significance. Preoperative serum sodium abnormalities
Table 3 Odds ratios for in-hospital mortality according to preoperative serum sodium, patient characteristics, and type of surgery. Odds
ratios [OR (95% confidence intervals)] are presented for the univariate and multivariate analysis (adjusted in a two-level analysis with
patient at the first level and site at the second level)
Serum sodium intervals OR (univariate model) P-value OR (multivariate analysis) P-value
Normal range (138–142 mmol litre−1) Reference Reference Reference
Severe hyponatraemia (Na ≤130 mmol litre−1) 3.5 (2.6–4.6) <0.0001 1.4 (1.0–2.0) 0.061
Moderate hyponatraemia (Na 131–135 mmol litre−1) 2.3 (1.9–2.7) <0.0001 1.3 (1.0–1.6) 0.033
136–137 mmol litre−1 Na range 1.4 (1.1–1.6) 0.0007 1.0 (0.8–1.2) 0.94
143–144 mmol litre−1 Na range 1.1 (0.9–1.3) 0.55 1.1 (0.9–1.3) 0.48
Moderate hypernatraemia (Na 145–149 mmol litre−1) 1.8 (1.4–2.3) <0.0001 1.3 (1.0–1.8) 0.074




























Distribution of patients who died
Number of cases, logarithmized
Observed mortality
Fig 1Distribution of sodium concentration-predictedmortality and contribution to totalmortality according to sodium concentration (inmillimoles per litre) in the
total study population. CI, confidence interval.












therefore remain an important biomarker of postoperative mor-
tality risk.
Our findings differ from those of previous studies in the sense
that in our study only severe hypernatraemiawas independently
associated with increased mortality after surgery. These results
are in contrast with the findings of Leung and colleagues16 17 in
the perioperative setting and studies in medical and critically ill
patients.9 11 20 In two separate studiess from a large American
database, Leung and colleagues16 17 found that both hyponatrae-
mia and hypernatraemia were independently associated with
increased mortality and incidence of postoperative complica-
tions. In a large cohort of patients from the Austrian Center
for Documentation and Quality Assurance in Intensive Care,
Funk and colleagues11 found that mild degrees of dysnatraemia
(hyponatraemia and hypernatraemia) were associated with
worse outcome. This was confirmed recently by Darmond and
colleagues9 in another large multicentre study in French ICUs.
From a physiological point of view, dysnatraemia originates
from disturbances in water balance;10 21 this is normally under
the control of antidiuretic hormone.14 21 Several preoperative
conditionsmay predispose patients to a derangedwater balance,
such as volume depletion, pain, nausea, and preoperative
co-morbid conditions, such as heart failure or cirrhosis. In the
context of hyponatraemia, in patients requiring long-term renal
replacement therapy, Waikar and colleagues22 demonstrated
that the association between mortality and hyponatraemia was
independent of antidiuretic hormone activity. This association
was also found in the SAPS II and APACHE II score23 24 validations
studies. In our study, we collected data for a wide range of
co-morbidities. It is possible that our results differ from previous
studies because we corrected better for preoperative co-morbid-
ities. Another possible explanation for the difference between
our results and previous literature is that we may have stratified
hyponatraemia inmoredetail. It is possible that the classification
used in our study allowed for a better stratification and therefore
amore robust correction for confounding factors in themultivari-
ate analysis. Nonetheless, the results regarding hypernatraemia
are consistent with the published literature.17 In themultivariate
analysis, after adjusting for confounding factors we found amore
than three-fold increase inmortality for patients presentingwith
serum sodium higher than 149 mmol litre−1 (OR 3.42). There are
several possible explanations for this finding. First, it is possible
that these patientswere dehydrated, whichwas not a variablewe
collected in our data set, and were thus unable to correct for it;
and secondly, it is possible that they were more exposed to sig-
nificant fluid and electrolyte shifts during the perioperative per-
iod.25 26 A further possible explanation could relate to other
adverse effects of hypernatraemia, such as increased peripheral
insulin resistance27 and decreased cardiac contractility.28 We
also investigated the urgency of surgery as a possible confound-
ing factor. In this sense, it is important to note that even if pa-
tients with hypernatraemia undergoing urgent and emergency
surgery had a highermortality than patients undergoing elective
surgery (Fig. 2), the relationship between severe hypernatraemia
and mortality was maintained after correcting for these factors.
These results have important implications in the periopera-
tive setting. Although from our analysis it is difficult to justify
serum sodium correction before surgery, dysnatraemia should
be seen as a warning flag or a biomarker for risk of mortality
and should prompt investigation for underlying disease pro-
cesses that may warrant treatment before the commencement
of surgery. In practice, our analysis suggests that preoperative
serumsodiumconcentrations could be used to stratify periopera-













































































































































































































































































































































































































































































































































































































behaves as a postoperativemortality biomarker related to the co-
morbidity status of surgical patients. Interestingly, although this
may seem obvious, our data suggest that clinicians do not use
serum sodium in this way. This is apparent when we look at
resource utilization. In our study, dysnatraemia was also asso-
ciated with different resource utilization in terms of ICU admis-
sion, use of ventilation, vasoactive drugs, central lines, and
cardiac output monitors, but not all patients in the highest risk
group used the same level of resources. Patients with moderate
and severe hypernatraemia showed an in-hospital mortality in
excess of 21%, but only <35% of this group were admitted to an
ICU. It is difficult to interpret these results, because there may
bemany reasons for which high-risk surgical patients are not ad-
mitted to a critical care unit after surgery,29 and can be explained
partly by different resource availability and practice among the
departments that took practice in the study; our results, however,
suggest that risk was either not recognized or not acted upon,
either for lack of resources or for clinical reasons.
Our study has several limitations. First, the original EuSOS
database was not designed to investigate the effect of preopera-
tive dysnatraemia on outcome. Second, we had no control on
the timing of the blood test before surgery (we only knew that it
was performed within 28 days before surgery). It is also not
knownwhether some of the patients had already received specif-
ic treatment for dysnatraemia before or after the blood test and
before or after surgery. It is also possible that severe hypernatrae-
mia was still associated with mortality even in the multivariate
analysis because other variables related to hypernatraemia
were not collected in the EuSOS database; for instance, there
was no descriptive description of volaemic status of these
patients.
Conclusions
Dysnatraemia is a common finding in patients about to undergo
surgery and is associated with increased mortality. However,
after correction for other risk factors, this association with mor-
tality is weakened, suggesting that other risk factors may be of
greater importance, and only severe hypernatraemia was inde-
pendently associated with increased mortality. Further research
is needed to establish whether preoperative measurement of
serum sodium has a valid role in assessment ofmortality risk be-
fore surgery and whether treatment of dysnatraemia before sur-
gery could improve outcome.
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Fig 2 Predictedmortality according to sodium concentration in the total study population and in elective and non-elective (urgent plus emergency) surgery. On the
y-axis,mortality rate (from0 to 1). On the x-axis, sodium range (inmillimoles per litre). Data are presented for the overall population (total; blue lines), for the elective
population (elective; green lines) and for the non-elective population (urgent + emergency; pink lines). For each of the three groups, the central line represents the
mean mortality for the sodium value and the top and bottom lines represent the 95% confidence interval.












grant from Nestle Health Sciences. R.P. is a member of the Asso-
ciate Editorial Board of the British Journal of Anaesthesia. Other
authors: none declared.
Funding
This study is a secondary study of the EuSOS project, which was
funded by the European Society of Intensive Care Medicine and
the European Society of Anaesthesiology.
References
1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estima-
tion of the global volume of surgery: a modelling strategy
based on available data. Lancet 2008; 372: 139–44
2. Ghaferi AA, Birkmeyer JD, Dimick JB. Complications, failure to
rescue, and mortality with major inpatient surgery in medi-
care patients. Ann Surg 2009; 250: 1029–34
3. Birkmeyer JD, Gust C, Dimick JB, Birkmeyer NJ, Skinner JS.
Hospital quality and the cost of inpatient surgery in the Uni-
ted States. Ann Surg 2012; 255: 1–5
4. Bentrem DJ, Cohen ME, Hynes DM, Ko CY, Bilimoria KY.
Identification of specific quality improvement opportunities
for the elderly undergoing gastrointestinal surgery. Arch
Surg 2009; 144: 1013–20
5. Crawford RS, Cambria RP, Abularrage CJ, et al. Preoperative
functional status predicts perioperative outcomes after infra-
inguinal bypass surgery. J Vasc Surg 2010; 51: 351–8; discus-
sion 8–9
6. Grocott MP, Pearse RM. Prognostic studies of perioperative
risk: robust methodology is needed. Br J Anaesth 2010; 105:
243–5
7. Munro J, Booth A, Nicholl J. Routine preoperative testing: a
systematic review of the evidence. Health Technol Assess
1997; 1: i–iv; 1–62
8. Reynolds TM, National Institute for Health and Clinical Excel-
lence, Clinical Scince Reviews Committee of the Association
for Clinical Biochmistry. National Institute for Health and
Clinical Excellence guidelines on preoperative tests: the use
of routine preoperative tests for elective surgery. Ann Clin
Biochem 2006; 43: 13–6
9. Darmon M, Diconne E, Souweine B, et al. Prognostic conse-
quences of borderline dysnatremia: pay attention tominimal
serum sodium change. Crit Care 2013; 17: R12
10. Reynolds RM. Disorders of sodiumbalance. BrMed J 2006; 332:
702–5
11. Funk GC, Lindner G, Druml W, et al. Incidence and prognosis
of dysnatremias present on ICU admission. Intensive Care Med
2010; 36: 304–11
12. Deubner N, Berliner D, Frey A, et al. Dysnatraemia in heart
failure. Eur J Heart Fail 2012; 14: 1147–54
13. Li M, Hu YH, Chen G. Hypernatremia severity and the risk of
death after traumatic brain injury. Injury 2013; 44: 1213–8
14. Maggiore U, Picetti E, Antonucci E, et al. The relation between
the incidence of hypernatremia and mortality in patients
with severe traumatic brain injury. Crit Care 2009; 13: R110
15. CallahanMA, DoHT, CaplanDW, Yoon-Flannery K. Economic
impact of hyponatremia in hospitalized patients: a retro-
spective cohort study. Postgrad Med 2009; 121: 186–91
16. Leung AA, McAlister FA, Rogers SO Jr, Pazo V, Wright A,
Bates DW. Preoperative hyponatremia and perioperative
complications. Arch Intern Med 2012; 172: 1474–81
17. Leung AA, McAlister FA, Finlayson SRG, Bates DW. Preopera-
tive hypernatremia predicts increased perioperative morbid-
ity and mortality. Am J Med, 2013; 126: 877–86
18. Sakr Y, Rother S, Ferreira AMP, et al. Fluctuations in serum so-
dium level are associated with an increased risk of death in
surgical ICU patients. Crit Care Med 2013; 41: 133–42
19. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in
Europe: a 7 day cohort study. Lancet 2012; 380: 1059–65
20. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the
critically ill is an independent risk factor for mortality. Am J
Kidney Dis 2007; 50: 952–7
21. Kumar S, Berl T. Sodium. Lancet 1998; 352: 220–8
22. Waikar SS, Curhan GC, Brunelli SM. Mortality associatedwith
low serum sodium concentration in maintenance hemodi-
alysis. Am J Med 2011; 124: 77–84
23. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute
Physiology Score (SAPS II) based on a European/North Ameri-
can multicenter study. JAMA 1993; 270: 2957–63
24. KnausWA, Draper EA,Wagner DP, Zimmerman JE. APACHE II:
a severity of disease classification system. Crit Care Med 1985;
13: 818–29
25. Roth E, Lax LC, Maloney JV Jr. Ringer’s lactate solution and
extracellular fluid volume in the surgical patient: a critical
analysis. Ann Surg 1969; 169: 149–64
26. Holte K. Pathophysiology and clinical implications of peri-op-
erative fluid management in elective surgery. Dan Med Bull
2010; 57: B4156
27. Bratusch-Marrain PR, DeFronzo RA. Impairment of insulin-
mediated glucose metabolism by hyperosmolality in man.
Diabetes 1983; 32: 1028–34
28. Lindner G, Kneidinger N, Holzinger U, Druml W, Schwarz C.
Tonicity balance in patients with hypernatremia acquired
in the intensive care unit. Am J Kidney Dis 2009; 54: 674–9
29. Pearse RM, Harrison DA, James P, et al. Identification and
characterisation of the high-risk surgical population in the
United Kingdom. Crit Care 2006; 10: R81
Handling editor: P. S. Myles
Serum sodium and in-hospital mortality | 69
 at Q
ueen M
ary, U
niversity of L
ondon on M
ay 12, 2016
http://bja.oxfordjournals.org/
D
ow
nloaded from
 
